AIEQ · Exit · 1d
weight 0.320% → 0 (exited)·stock up 8.8% in the 30 days before
Jul 1·entry $203.20·now $261.75
IQVIA HOLDINGS INC.
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.
Close · 3M
+57.61%
None of the tracked AI ETFs currently hold this name.
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
AIEQ · Exit · 1d
weight 0.320% → 0 (exited)·stock up 8.8% in the 30 days before
Jul 1·entry $203.20·now $261.75
AIEQ · Weight increase · 2d
weight 0.280% → 0.310% (+0.030 pp)·stock up 15.1% in the 30 days before
Jun 25·entry $186.43·now $261.75Chased
AIEQ · New entry · 1d
weight 0 → 0.300% (new)·stock up 16.3% in the 30 days before
May 30·entry $186.82·now $261.75Chased
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.
AI ETFs PQUS and QRFT have both recently exited IQVIA, signaling a cautious or bearish stance from these algorithms. This action aligns with the framework's 'Fail' verdict, as insufficient data prevents a confident endorsement of the company against all stringent value investing criteria.
IQVIA demonstrates a strong circle of competence within the stable life sciences sector and possesses an identifiable economic moat through its scale, data, and technology advantages. However, the analysis is incomplete due to a lack of comprehensive data on management's capital allocation, long-term financial health trends, and the existence of a clear margin of safety. Consequently, the company does not pass all criteria required by this rigorous value investing framework.
Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.